We came across a bullish thesis on Rocket Pharmaceuticals, Inc. (RCKT) on Twitter by sharkbiotech. In this article, we will summarize the bulls’ thesis on RCKT. Rocket Pharmaceuticals, Inc. (RCKT)’s share was trading at $8.66 as of March 4th.
A researcher studying a microscopic image of a gene therapy under a microscope.
Rocket Pharmaceuticals (RCKT) is developing gene therapy for rare cardiac diseases, with its lead drug targeting Danon disease, a fatal condition caused by a mutation in...
